Aspartate and glutamate mimetic structures in biologically active compounds

被引:15
作者
Stefanic, P [1 ]
Dolenc, MS [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
glutamate; aspartate; mimetics; excitatory amino acid receptor agonists and antagonists; glutamate racemase inhibitors; RGD mimetics; fibrinogen receptor antagonists; vitronectin receptor antagonists;
D O I
10.2174/0929867043455512
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glutamate and aspartate are frequently recognized as key structural elements for the biological activity of natural peptides and synthetic compounds. The acidic side-chain functionality of both the amino acids provides the basis for the ionic interaction and subsequent molecular recognition by specific receptor sites that results in the regulation of physiological or pathophysiological processes in the organism. In the development of new biologically active compounds that possess the ability to modulate these processes, compounds offering the same type of interactions are being designed. Thus, using a peptidomimetic design approach, glutamate and aspartate mimetics are incorporated into the structure of final biologically active compounds. This review covers different bioisosteric replacements of carboxylic acid alone, as well as mimetics of the whole amino acid structure. Amino acid analogs presented include those with different distances between anionic moieties, and analogs with additional functional groups that result in conformational restriction or alternative interaction sites. The article also provides an overview of different cyclic structures, including various cycloalkane, bicyclic and heterocyclic analogs, that lead to conformational restriction. Higher di- and tripeptide mimetics in which carboxylic acid functionality is incorporated into larger molecules are also reviewed. In addition to the mimetic structures presented, emphasis in this article is placed on their steric and electronic properties. These mimetics constitute a useful pool of fragments in the design of new biologically active compounds, particularly in the field of RGD mimetics and excitatory amino acid agonists and antagonists.
引用
收藏
页码:945 / 968
页数:24
相关论文
共 99 条
[1]   (S)-Homo-AMPA, a specific agonist at the mGlu(6) subtype of metabotropic glutamic acid receptors [J].
Ahmadian, H ;
Nielsen, B ;
Brauner-Osborne, H ;
Johansen, TN ;
Stensbol, TB ;
Slok, FA ;
Sekiyama, N ;
Nakanishi, S ;
KrogsgaardLarsen, P ;
Madsen, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) :3700-3705
[2]   LOW-MOLECULAR-WEIGHT, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS [J].
ALIG, L ;
EDENHOFER, A ;
HADVARY, P ;
HURZELER, M ;
KNOPP, D ;
MULLER, M ;
STEINER, B ;
TRZECIAK, A ;
WELLER, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4393-4407
[3]   SYNTHESIS AND ACTIVITY OF A POTENT N-METHYL-D-ASPARTIC ACID AGONIST, TRANS-1-AMINOCYCLOBUTANE-1,3-DICARBOXYLIC ACID, AND RELATED PHOSPHONIC AND CARBOXYLIC-ACIDS [J].
ALLAN, RD ;
HANRAHAN, JR ;
HAMBLEY, TW ;
JOHNSTON, GAR ;
MEWETT, KN ;
MITROVIC, AD .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2905-2915
[4]   Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group III [J].
Amori, L ;
Costantino, G ;
Marinozzi, M ;
Pellicciari, R ;
Gasparini, F ;
Flor, PJ ;
Kuhn, R ;
Vranesic, I .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) :1447-1450
[5]   Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists [J].
Archibald, SC ;
Head, JC ;
Gozzard, N ;
Howat, DW ;
Parton, TAH ;
Porter, JR ;
Robinson, MK ;
Shock, A ;
Warrellow, GJ ;
Abraham, WM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) :997-999
[6]   Pyrrolidinones derived from (S)-pyroglutamic acid.: Part 1.: Conformationally constrained glutamate [J].
Bailey, JH ;
Cherry, DT ;
Dyer, J ;
Moloney, MG ;
Bamford, MJ ;
Keeling, S ;
Lamont, RB .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 2000, (16) :2783-2792
[7]   4-alkylidenyl glutamic acids, potent and selective GluR5 agonists [J].
Baker, SR ;
Bleakman, D ;
Ezquerra, J ;
Ballyk, BA ;
Deverill, M ;
Ho, K ;
Kamboj, RK ;
Collado, I ;
Domínguez, C ;
Escribano, A ;
Mateo, AI ;
Pedregal, C ;
Rubio, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (16) :1807-1810
[8]   The synthesis of [2.2.2]bicyclooctane and [3.1.1]bicycloheptane based amino acids as constrained glutamate analogues. [J].
Baker, SR ;
Hancox, TC .
TETRAHEDRON LETTERS, 1999, 40 (04) :781-784
[9]   Disubstituted indazoles as potent antagonists of the integrin αvβ3 [J].
Batt, DG ;
Petraitis, JJ ;
Houghton, GC ;
Modi, DP ;
Cain, GA ;
Corjay, MH ;
Mousa, SA ;
Bouchard, PJ ;
Forsythe, MS ;
Harlow, PP ;
Barbera, FA ;
Spitz, SM ;
Wexler, RR ;
Jadhav, PK .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) :41-58
[10]   1-AMINOALKYLPHOSPHONOUS ACIDS .1. ISOSTERES OF THE PROTEIN AMINO-ACIDS [J].
BAYLIS, EK ;
CAMPBELL, CD ;
DINGWALL, JG .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1984, (12) :2845-2853